Mild ovarian stimulation for in vitro fertilization: are we ready to change? A meta-analysis.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 24192422)

Published in Gynecol Obstet Invest on November 02, 2013

Authors

Thabo Matsaseng1, Thinus Kruger, Wilhelm Steyn

Author Affiliations

1: Reproductive Medicine Unit, University of Stellenbosch, Tygerberg, South Africa.

Associated clinical trials:

INTEnsity of ovariaN Stimulation and Embryo Quality (INTENS-EQ) | NCT04983173

Articles by these authors

World Health Organization reference values for human semen characteristics. Hum Reprod Update (2009) 7.71

Intrauterine insemination: a systematic review on determinants of success. Hum Reprod Update (2002) 1.15

Association between clomiphene citrate and visual disturbances with special emphasis on central retinal vein occlusion: a review. Gynecol Obstet Invest (2010) 1.03

Selectivity of hyaluronic acid binding for spermatozoa with normal Tygerberg strict morphology. Reprod Biomed Online (2009) 0.91

Nevirapine plasma concentrations in premature infants exposed to single-dose nevirapine for prevention of mother-to-child transmission of HIV-1. S Afr Med J (2011) 0.85

Total perinatally related losses at Tygerberg Hospital - a comparison between 1986, 1993 and 2006. S Afr Med J (2010) 0.84

Embryo selection criteria based on morphology VERSUS the expression of a biochemical marker (sHLA-G) and a graduated embryo score: prediction of pregnancy outcome. J Assist Reprod Genet (2010) 0.83

Luteal phase support in in vitro fertilization: meta-analysis of randomized trials. Gynecol Obstet Invest (2005) 0.81

Hypertension in pregnancy. Cardiovasc J S Afr (2002) 0.78

The relationship between seminal leukocytes, oxidative status in the ejaculate, and apoptotic markers in human spermatozoa. Syst Biol Reprod Med (2013) 0.77

A linear karyotypic association between PB-I, PB-II and blastomere using sequentially performed comparative genome hybridization with no association established between karyotype, morphologic, biochemical (sHLA-G expression) characteristics, blastocyst formation and subsequent pregnancy outcome. Gynecol Obstet Invest (2012) 0.75